Top Markets
#1 City Boy City Boy +19.56%
#2 pippin pippin +18.79%
#3 TRIA TRIA +16.20%
#4 Osaka Protocol Osaka Protocol +14.57%
#5 River Pts River Pts +13.00%
#6 Aria.AI Aria.AI +12.75%
#7 Janction Janction +11.53%
#8 Infinity Ground Infinity Ground +11.29%
#9 Strategic Oil Supply Strategic Oil Supply +10.67%
#10 Orochi Network Orochi Network +9.45%
Coin of the day
City Boy City Boy
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
शेयरों में रैंक #98
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
शेयर मूल्य
$37.45
मार्केट कैप
$166.43B
बदलाव (1 दिन)
-2.55%
बदलाव (1 वर्ष)
-53.09%
देश
DK
व्यापार Novo Nordisk A/S (NVO)

श्रेणी

Healthcare
Novo Nordisk A/S (NVO) के लिए P/S अनुपात
January 2026 को P/S अनुपात TTM: 5.21
Novo Nordisk A/S की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/S अनुपात (TTM) 5.21 है। 2026 के अंत में, कंपनी का P/S अनुपात 0 था।
Novo Nordisk A/S के लिए 2026 से 2026 तक P/S अनुपात का इतिहास
हर वर्ष के अंत में P/S अनुपात
वर्ष P/S अनुपात परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।
समान कंपनियों या प्रतिस्पर्धियों के लिए P/S अनुपात
कंपनी P/S अनुपात P/S अनुपात में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.90 89.90%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.40 3.60%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.14 17.70%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.04 -41.63%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
12.90 147.31%
NL